(Q43145571)
Statements
Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia (English)
Anna Dmoszynska
Tadeusz Robak
Philippe Solal-Céligny
Javier Loscertales
John Catalano
Boris V Afanasiev
Christian H Geisler
Marco Montillo
Ilya Zyuzgin
Caroline Dartigeas
András Rosta
Jörg Maurer
Myriam Mendila
M Wayne Saville
Nancy Valente
Michael K Wenger
Sergey I Moiseev